NEW YORK (AP) -- Emphasys Medical Inc., which developed a medical device to treat emphysema, has canceled its plans for an initial public offering, citing market conditions, according to a Securities and Exchange Commission filing Monday.
NEW YORK (AP) -- Emphasys Medical Inc., which developed a medical device to treat emphysema, has canceled its plans for an initial public offering, citing market conditions, according to a Securities and Exchange Commission filing Monday.
